Skip to main content

Oregon State Flag An official website of the State of Oregon »

Rulemaking advisory committees (RAC)

Advisory committees

Advisory committee meetings are open to the public. Due to time limitations and to ensure that public comments are correctly recorded, individuals are strongly encouraged to submit public comments in writing via email to DFR.rules@oregon.gov.

Current committees

  • Securities Mid-Point Fees RAC

    Directs the Division of Financial Regulation, on behalf of the director of the Department of Consumer and Business Services, to set securities fees by rule and to permit an adjustment to those fees every two years.

    More details
  • Auto Rating Fairness RAC

    The rulemaking will establish data reporting requirements for auto insurance issuers that will give us the ability to identify discriminatory effects on protected classes.

    More details
  • Insurance Notices HB 2563

    Requires insurers to give a clear and reasonable written explanation for any increase in the amount of premium the insured must pay.

    Next meeting: Aug. 27, 2025
    More details
  • Ground Ambulance HB 3243 RAC

    The bill requires health benefit plans to reimburse ground ambulance services organizations at locally established rates. The bill requires ground ambulance service providers to report locally established rates to DCBS.

  • Network Adequacy SB 822 RAC

    Extends Oregon’s network adequacy standards to include large group health benefit plans and introduce clear, quantitative standards for measuring geographic access, and appointment wait times.

  • Rate Review HB 2564 RAC

    House Bill 2564 (2025) made certain modifications to the existing rate review process, requiring DCBS specify the form and manner of a consumer-friendly summary document in an easily understood manner.

    Next meeting: Aug. 6, 2025
    More details
  • Prosthetics and Orthotics SB 699 RAC

    This committee will amend language to ORS 836-052-1001 to comply with SB 699's directives.

  • NAIC Accreditation SB 831 RAC

    NAIC accreditation standards and related model laws and regulations are revised to address emerging issues. SB 831 (2025).

  • 2026 ORP Payment Parameters RAC

    The amendment to OAR 836-150-0040 will define payment parameters for the Oregon Reinsurance Program during plan year 2026.

  • Prior Authorization HB 3134 RAC

    House Bill 3134 (2025) revises that no later than March 1 of each calendar year, DCBS must publish on its website the aggregate prior authorization data that is reported in a format that does not identify the insurer.

  • Behavioral Health Parity SB 824 RAC

    Senate Bill 824 (2025) removes the sunset provisions from HB 3046 (2021) and reinstates the quantitative data reporting requirements from HB 3046.

  • IIPRC Opt-Out RAC

    Rule adoption is needed to complete Oregon’s opt-out of the identified Compact Uniform Standards.-

  • The Licensing of Public Adjusters RAC

    Rulemaking intended to clarify the roles and responsibilities of each adjuster type.

  • NCCI Statistical Plan changes RAC

    The proposed rule changes will improve the quality and timeliness of data collected as well as ease the administrative burden on both the DPT program and manufacturers.

  • 2026 Standard Health Benefits RAC

    Changes made this year require DCBS to reduce certain benefits on the Standard Silver plan. Also, this rulemaking would reassert the existing rules listing the prosthetic and orthotic devices that must be covered.

  • Licensing of Pharmacy Benefit Managers RAC

    Modifies the definition of "pharmacy benefit manager" and imposes new requirements on pharmacy benefit managers.

    More details
  • Drug Price Transparency RAC

    Proposed rulemaking process that aims to update and amend the current administrative rules related to the Oregon Prescription Drug Price Transparency (DPT) program

    More details
  • Gender-Affirming Treatment (HB 2002) RAC

    HB 2002 prohibits a carrier offering a health benefit plan from denying or limiting coverage for medically necessary gender affirming treatment that is prescribed in accordance with accepted standards of care.

    More details